Fig. 3From: Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case reportCRP levels evolution with and without tofacitinib treatment. CRP: C-reactive protein; b.i.d: twice per day; SAPHO: synovitis, acne, pustulosis, hyperostosis, and osteitisBack to article page